Breastfeeding, Avoiding Sugary Drinks Reduce Later Obesity Risk in Offspring
TUESDAY, March 18, 2025 -- Adequate breastfeeding (BF) and avoidance of sugary beverages in early life may reduce the risk for preadolescent obesity in infants exposed to gestational diabetes (GDM), according to a study published online March 12 in Obesity.
Baiyang Sun, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues evaluated the impact of fetal exposure to GDM severity, infant BF, and sugary beverage intake on preadolescent overweight and obesity. The analysis included 850 mother-infant dyads exposed to GDM.
The researchers found that among preadolescents (aged 6 to 11 years), 17.6 percent had overweight, 18.2 percent had moderate obesity, and 7.6 percent had severe obesity. Compared with adequate BF and no sugar-sweetened beverages [SSB] and 100 percent fruit juice [FJ], the risk for obesity was higher for both inadequate BF with SSB/FJ intake (adjusted relative risk [aRR], 1.55) and for adequate BF with SSB/FJ intake (aRR, 1.50), independent of GDM severity and covariates. The risk for severe obesity was more than tripled with inadequate BF with SSB/FJ intake versus adequate BF without SSB/FJ intake (aRR, 3.80).
"BF adequacy and avoidance of sugary beverages in early life are modifiable lifestyle behaviors that may combat preadolescent obesity in infants exposed to GDM, suggesting potential longer-term benefits on child cardiometabolic health," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
TUESDAY, Sept. 30, 2025 -- Patients weighing more than 450 lb face considerable limitations when attempting to access specialty care, according to a research letter published...
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
TUESDAY, Sept. 30, 2025 -- Patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have better long-term outcomes compared with those taking...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.